Fayuvi is Ultragenyx's second approved gene therapy after Genglycos (pariglasgene brecaparvovec) for glycogen storage disease ...
Generating good-quality patient experience data (PED) is becoming increasingly important for medicine development, and ...
Boardrooms, Advisory Boards, and governance teams saw plenty of activity in August, with companies across biotech, ...
Frehemgo (denecimig, also known as Mim8) – which picked up its first world approval in Saudi Arabia a few days ago – has been ...
Around 1,000 patients in England with a form of incurable breast cancer will be able to get access to AstraZeneca and Daiichi ...
Chinese tech giant ByteDance – best known as the parent of social media app TikTok – has completed a $290 million financing ...
Avalere Health was the most successful agency, winning three Golds, a Silver and the highly contested accolade of PMi Agency ...
Curium's radioligand therapy Bexlutry has been approved in the US as a generic – or 'radioligand equivalent' (RLE) – of ...
Jiangsu Hengrui Pharma's oral thrombopoietin (TPO) receptor agonist hetrombopag has been approved in China to treat low ...
At present, the only FDA-approved oral therapies for HAE are BioCryst's Orladeyo (berotralstat) and KalVista Pharma's Ekterly ...
The FDA has published the design of its expedited Investigational New Drug (IND) pilot, part of a plan to restore US competitiveness in clinical research, and will now accept applications to take part ...
The Danish Group stated that the new corporate culture – dubbed 'The Novo Way' – centres around four Cs; namely, customer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results